{
    "Trade/Device Name(s)": [
        "BIOLAND G-423 BLOOD GLUCOSE MONITORING SYSTEM",
        "BIOLAND G-423 BLOOD GLUCOSE MONITORING SYSTEM MODEL G-423",
        "Bioland G-423 Blood Glucose Monitoring System, Model G-423"
    ],
    "Submitter Information": "BIOLAND TECHNOLOGY LTD.",
    "510(k) Number": "K113077",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053593"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW"
    ],
    "Summary Letter Date": "July 17, 2012",
    "Summary Letter Received Date": "August 1, 2012",
    "Submission Date": "October 14, 2011",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood (fingertips)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Bioland G-423 Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor technology",
        "Glucose oxidase (A. Niger)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for BIOLAND G-423 Blood Glucose Monitoring System for quantitative measurement of glucose in capillary whole blood",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from fingertips for self-testing by people with diabetes at home to aid in monitoring diabetes control; not for diagnosis, screening, or neonatal use",
    "fda_folder": "Clinical Chemistry"
}